RAHWAY, N.J. – Merck stock jumped to a 52-week high at the opening of trading Thursday morning after the company released fourth quarter and full year results. Yet, on a GAAP (Generally Accepted ...

We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished ...

(Reuters) - Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday. As part of ...

Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...

Three months after revealing that its respiratory syncytial virus (RSV) preventive antibody clesrovimab had passed muster in a phase 2b/3 trial, Merck is putting numbers to the claim. Clesrovimab ...

Merck KGaA said it’s seeing the beginning of a post-Covid pandemic rebound in life sciences as it reaffirmed the group’s sales and profit guidance for the full year. The German science and ...

Shares of Microsoft and Merck are posting losses Thursday morning, dragging the Dow Jones Industrial Average into negative territory. Supported by world-class markets data from Dow Jones and ...

International science and technology firm Merck has announced investment of over £4 million in its Life Science facility in Livingston, bringing new jobs to the town. Did you know with a Digital ...

Shares of Microsoft and Merck are trading lower Thursday morning, sending the Dow Jones Industrial Average into negative territory. Supported by world-class markets data from Dow Jones and FactSet ...

Oct 17 (Reuters) - German science and technology group Merck (MRCG.DE), opens new tab ... forestry exports from West Coast 10:28 PM UTC · Updated ago category Wall Street drafts Trump wish ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from STRIDE-8, a Phase 3 trial evaluating CAPVAXIVE™ (Pneumococcal ...